San Diego, CA (PRWEB) July 23, 2013
BIT Group has now concluded the full product launch of the DRG: Hybrid XL Analyzer and plans to showcase the revolutionary hybrid system design at the upcoming AACC Clinical Lab Expo in Houston, TX, USA, July 30-August 1, 2013. The analyzer, which is now in service by end users, will be part of BIT Group’s “Evolution of the Revolution” exhibit which demonstrates diagnostic system design at its best.
The DRG: Hybrid XL Analyzer‘s innovative and unique technology allows, for the first time, the simultaneous measurement of immunoassays and clinical chemistry parameters including turbidimetric tests in one work routine. BIT Group, a complete contract product development, manufacturing services and after-sales service provider to medical and industrial instrument OEM clients, partnered with DRG Diagnostics to develop the DRG:HYBRID XL Analyzer. Following the system requirements defined by DRG, BIT Group provided the hybrid technology concept and developed the core product idea and industrial design through to engineering, prototype, validation and final production.
The DRG:HYBRID XL fully-automated analyzer is ideal for small and medium-sized labs. It is also suitable for high-workload laboratories performing special routine and niche parameters automatically. The analyzer is flexible enough to measure 40 different tests from one sample or just one or two tests from 20 samples. Additionally, the unique concept of the DRG:HYBRID XL allows each user to combine individual diagnostic panels from immunoassays and clinical chemistry. Further information on the DRG:HYBRID XL Analyzer can be found on DRG’s website.
Follow BIT Group’s Hybrid
Copyright©2012 Vocus, Inc.
All rights reserved